Moderna Inc. stock underperforms Wednesday when compared to competitors

Shares of Moderna Inc. MRNA, -2.21% slipped 2.21% to $76.56 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index COMP, -0.80% falling 0.80% to 11,768.73 and Dow Jones Industrial Average DJIA, -0.57% falling 0.58% to 28,514.00. The stock’s fall snapped a five-day winning streak. Moderna Inc. closed $18.65 below its 52-week high ($95.21), which the company achieved on July 17th.

The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. ABBV, -0.66% fell 0.67% to $86.07 and Amgen Inc. AMGN, -0.70% fell 0.71% to $237.65. Trading volume (6.6 M) remained 4.1 million below its 50-day average volume of 10.7 M.

Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Read More Here...

Bookmark the permalink.

Comments are closed.